Search GIPL
Global Innovative Platforms Inc.
OTC · CIK 1837774
Last close0.5
Daily change+0.00 (0.00%)
10 Years gain-87.50%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GIPL · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0930
Fundamental
33.4Momentum
n/aAcceleration
n/aConfidence
78.0Annual Revenue5
Quarterly Revenue23
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency5.5 / 20
Balance Sheet13.7 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTMn/aINSUFFICIENT_HISTORY
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin100%OK
Operating Margin-349.49%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-343.83%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO0.52xOK
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $0.00 | $0.00 | -$718,251.00 | -$560,740.00 | n/a | n/a | n/a | n/a | -830.26% | 39.37M |
| 2025 FY Sep 30, 2024 | $0.00 | $0.00 | -$136,197.00 | -$87,378.00 | n/a | n/a | n/a | n/a | n/a | 26.63M |
| 2024 FY Sep 30, 2023 | $0.00 | $0.00 | -$282,786.00 | -$234,793.00 | n/a | n/a | n/a | n/a | n/a | 619,085 |
| 2023 FY Sep 30, 2022 | $0.00 | $0.00 | -$53,816.00 | -$53,620.00 | n/a | n/a | n/a | n/a | n/a | 619,085 |
| 2022 FY Sep 30, 2021 | $0.00 | $0.00 | -$73,273.00 | $262.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $187,200.00 | sum latest 4 fiscal quarters Revenue | OK | 0001376474-26-000564, 0001731122-26-000257 |
| Revenue Growth TTM | n/a | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | INSUFFICIENT_HISTORY | 0001376474-26-000564, 0001731122-26-000257 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001731122-26-000053 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001731122-26-000053 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001731122-26-000053 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001376474-26-000564, 0001731122-26-000257 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001376474-26-000564, 0001731122-26-000257 |
| Operating Margin | -349.49% | Operating Income / Revenue | OK | 0001376474-26-000564, 0001731122-26-000257 |
| ROIC | -343.83% | NOPAT / Average Invested Capital | OK | 0001376474-26-000564, 0001731122-26-000257 |
| Net Debt / CFO | 0.52x | Net Debt / CFO | OK | 0001376474-26-000564, 0001376474-26-000389 |
| Current Ratio | 34.73x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 43.49x | (Cash + Short-term Investments) / Total Debt | OK | 0001376474-26-000564 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |